Holy Stone Healthcare Co., Ltd.
Holy Stone Healthcare Co., Ltd. develops and sells hyaluronic acid-related therapeutic products in Taiwan. The company offers RenehaVis, a product designed to relive pain and stiffness of the knee joint; SportVis, a treatment to relive the pain and optimize the recovery of tendon and ligament injuries; TRUD, a treatment that allows mucosal tissue to heal naturally and reduces the symptoms of ulce… Read more
Market Cap & Net Worth: Holy Stone Healthcare Co., Ltd. (4194)
Holy Stone Healthcare Co., Ltd. (TWO:4194) has a market capitalization of $31.46 Million (NT$1.04 Billion) as of March 19, 2026. Listed on the TWO stock exchange, this Taiwan-based company holds position #27876 globally and #1761 in its home market, demonstrating a -3.39% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Holy Stone Healthcare Co., Ltd.'s stock price NT$7.13 by its total outstanding shares 145974400 (145.97 Million).
Holy Stone Healthcare Co., Ltd. Market Cap History: 2026 to 2026
Holy Stone Healthcare Co., Ltd.'s market capitalization history from 2026 to 2026. Data shows growth from $31.46 Million to $31.46 Million (0.00% CAGR).
Holy Stone Healthcare Co., Ltd. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Holy Stone Healthcare Co., Ltd.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 4194 by Market Capitalization
Companies near Holy Stone Healthcare Co., Ltd. in the global market cap rankings as of March 19, 2026.
Key companies related to Holy Stone Healthcare Co., Ltd. by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Holy Stone Healthcare Co., Ltd. Historical Marketcap From 2026 to 2026
Between 2026 and today, Holy Stone Healthcare Co., Ltd.'s market cap moved from $31.46 Million to $ 31.46 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | NT$31.46 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Holy Stone Healthcare Co., Ltd. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $31.46 Million USD |
| MoneyControl | $31.46 Million USD |
| MarketWatch | $31.46 Million USD |
| marketcap.company | $31.46 Million USD |
| Reuters | $31.46 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.